510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2140-2015Class II

ATTUNE CONV RP CR ARTICULATION SURFACE SZ1, 2, 9, and 10

Depuy Orthopaedics Inc. / initiated 2015-06-12 / Terminated / root cause: design

DePuy Orthopaedics, Inc. began a recall of ATTUNE CONV RP CR ARTICULATION SURFACE SZ1, 2, 9, and 10 INTENDED USE: The Tibial Articulation Surface Trial snaps together with the Shim component to function... on . FDA classified it as Class II and gives the reason as "Potential for the Balseal, a small wire spring coil located on the post feature of the ATTUNE Knee Tibial Articulation Surface Instruments used in trialing to become damaged and disassociate (come off). If the Balseal...". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-2140-2015
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Depuy Orthopaedics Inc.
Product
ATTUNE CONV RP CR ARTICULATION SURFACE SZ1, 2, 9, and 10 INTENDED USE: The Tibial Articulation Surface Trial snaps together with the Shim component to function as the Insert Trial during a total knee replacement. A Balseal is attached to each of the two post features on the Articulation Surface to provide a connection force between the Tibial Articulation Surface and Shim to ensure secure engagement between the components.
Product code
MBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer
Reason for recall
Potential for the Balseal, a small wire spring coil located on the post feature of the ATTUNE Knee Tibial Articulation Surface Instruments used in trialing to become damaged and disassociate (come off). If the Balseal is separated from the post, it has the potential to enter the surgical site and be left in the patient if the surgeon is unaware of the disassociation.
Root cause tag
design
FDA root cause
Device Design
Action
URGENT INFORMATION: MEDICAL DEVICE CORRECTION was issued for all lots of the affected devices. The device correction is to inform US Distributors and Medical Professionals about the issue, how to prevent the issue, and any actions to take. US Distributors will provide Hospitals/User Facilities with the Medical Professional Notice and Acknowledgment Cards. US Distributors will also work with the sales consultants to ensure all consultants complete sales training regarding this issue.
Quantity in commerce
13964 units
Distribution
Worldwide Distribution - US including AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY and Internationally to CANADA , AUSTRALIA, AUSTRIA, BELGIUM, ENGLAND/ UK, FRANCE, GERMANY, HONG KONG, INDIA, INDONESIA, IRELAND, ISRAEL, ITALY, JAPAN, JAPAN, MALAYSIA, NETHERLANDS, NEW ZEALAND, SINGAPORE, SLOVAKIA, SOUTH AFRICA, SOUTH KOREA, SPAIN & IBERIA, SWEDEN, SWITZERLAND, THAILAND, UAE, CHILE, COLOMBIA, MEXICO, PERU, and PUERTO RICO.
Product codes and lots
Product Codes:254500981, 254500982, 254501989, and 254501990. GTIN: 10603295135586, 10603295135593, 10603295423492, and 10603295423959.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2140-2015
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2137-2015Class IITerminatedVoluntary: Firm initiated
Z-2138-2015Class IITerminatedVoluntary: Firm initiated
Z-2139-2015Class IITerminatedVoluntary: Firm initiated
Z-2140-2015Class IITerminatedVoluntary: Firm initiated
Z-2141-2015Class IITerminatedVoluntary: Firm initiated
Z-2142-2015Class IITerminatedVoluntary: Firm initiated
Z-2143-2015Class IITerminatedVoluntary: Firm initiated
Z-2144-2015Class IITerminatedVoluntary: Firm initiated
Z-2145-2015Class IITerminatedVoluntary: Firm initiated
Z-2146-2015Class IITerminatedVoluntary: Firm initiated